<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-146614</identifier>
<setSpec>0001-7310</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Calcinosis Cutis and Calciphylaxis</dc:title>
<dc:description xml:lang="en">Calcinosis cutis (CC) is defined as the deposition of calcium salts in the skin. The condition is divided into 5 types: calciphylaxis and dystrophic, metastatic, idiopathic, and iatrogenic CC. Dystrophic CC is the most common form and usually occurs in association with autoimmune diseases. CC can be treated surgically or with the use of drugs such as diltiazem, bisphosphonates, warfarin, ceftriaxone, probenecid, minocycline, or aluminum hydroxide. Calciphylaxis is defined as calcification of the media of small- and medium-sized blood vessels in the dermis and subcutaneous tissue. Clinically, calciphylaxis causes livedo racemosa, which progresses to retiform purpura and skin necrosis. First-line treatment is with sodium thiosulfate. We present a review of the calcifying disorders of the skin, focusing on their diagnosis and treatment (AU)</dc:description>
<dc:creator>Linares-Barrios, M</dc:creator>
<dc:creator>Ossorio-García, L</dc:creator>
<dc:creator>Jiménez-Gallo, D</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La calcinosis cutis (CC) se define como el depósito de sales de calcio en la piel. Esta entidad se clasifica en 5 tipos que incluyen la CC distrófica, metastásica, idiopática, iatrogénica y calcifilaxis. La calcificación distrófica constituye el tipo más frecuente y aparece principalmente en enfermedades autoinmunes. El tratamiento de la CC incluye la extirpación quirúrgica o el uso de fármacos como diltiazem, bifosfonatos, warfarina, ceftriaxona, probenecid, minociclina e hidróxido de aluminio. La calcifilaxis se define como la calcificación de la capa media de vasos de pequeño y mediano tamaño de la dermis y tejido celular subcutáneo. Clínicamente se manifiesta como un síndrome de livedo racemosa que progresa a púrpura retiforme y necrosis cutánea. La primera línea de tratamiento es el tiosulfato sódico. El objetivo de esta revisión es proporcionar un análisis de los diferentes trastornos de calcificación cutánea enfocada en su diagnóstico y tratamiento (AU)</dc:description>
<dc:source>Actas Dermosifiliogr;106(10): 785-794, dic. 2015. tab, ilus</dc:source>
<dc:identifier>ibc-146614</dc:identifier>
<dc:title xml:lang="es">Calcinosis cutis y calcifilaxis</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d13256^s22012</dc:subject>
<dc:subject>^d7231^s22080</dc:subject>
<dc:subject>^d27768^s22073</dc:subject>
<dc:subject>^d29384^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d15261^s22073</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24388^s22012</dc:subject>
<dc:subject>^d30506^s22012</dc:subject>
<dc:subject>^d2148^s22011</dc:subject>
<dc:subject>^d1333^s22012</dc:subject>
<dc:subject>^d30931^s22012</dc:subject>
<dc:subject>^d29286^s22012</dc:subject>
<dc:subject>^d2148^s22016</dc:subject>
<dc:subject>^d29286^s22027</dc:subject>
<dc:subject>^d4220^s22073</dc:subject>
<dc:subject>^d23216^s22073</dc:subject>
<dc:subject>^d2148^s22009</dc:subject>
<dc:subject>^d1731^s22045</dc:subject>
<dc:subject>^d1333^s22027</dc:subject>
<dc:type>article</dc:type>
<dc:date>201512</dc:date>
</metadata>
</record>
</ibecs-document>
